These findings suggest that GFAP (p = 0.0015), NfL (p = 0.001), TAU (p = 0.0401), and UCH-L1 (p < 0.0001) plasmatic levels may be useful to predict poor COVID-19 outcome (Fig. 3). This evidence concerns the gene UCHL1 and COVID-19.